OCL 500 Treatment of Women With Symptomatic Uterine Fibroids
NCT03427671
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Uterine Fibroid
Myoma
Leiomyoma
Interventions
DEVICE:
Occlusin 500 Microspheres
Sponsor
IMBiotechnologies Ltd.